key opinion leaders

3.21.2014 KOL Management

Selecting the Right Key Opinion Leader is Imperative in an Era of Increased Transparency

By Jennifer Harrell, Research Analyst GlaxoSmithKline recently announced that it will create an internal team of doctors tasked with educating peers about its products. In December 2013, GSK decided to stop hiring external speakers. The company...
 

12.31.2013 Strategic Planning

New Year’s Resolutions for Pharma Teams

By Victoria Cavicchi, Research Analyst As 2013 comes to a close, the Pharmaceutical and Life Science industries are gearing up for new challenges and new opportunities in 2014. Cutting Edge Information is pleased to present a snapshot of our 2014...
 

12.18.2013 Fair-Market Value

Watch Your Service Fees So That CMS Doesn’t Have To

By Jacob Presson, Research Analyst After the Sunshine Act was released and a Final Rule was issued in early 2013, pharmaceutical companies geared up to make sure that their reporting and disclosure systems were in good working order.  Determining...
 

11.21.2013

Setting Fair-Market Value Based on Salary? Try KOL Activity Instead

By Elio Evangelista, Director of Operations Having just completed a new benchmarking study on fair-market value (FMV) rates in the Middle East, Cutting Edge Information uncovered a few important trends that may also affect country-level teams in...
 

10.3.2013 KOL Management

Discussion Leader and Clear Goals Set Pharmaceutical Advisory Boards Up for Success

By Yanis Saradjian, Director of Consulting The pharmaceutical industry has always turned to experts and key opinion leaders to shape and inform company policy.  Despite increasing rules on how companies are allowed to interact with physicians,...
 

9.24.2013 Medical Affairs

Great Moderators Key to Pharmaceutical Advisory Board Success

By Jacob Presson, Research Analyst Pharmaceutical companies are evolving their advisory board strategies to keep pace with the rapid changes that the entire industry is experiencing. As payer demands increase in complexity, the importance of engaging...
 

9.19.2013 Medical Affairs

Six Steps to Hosting a Successful Pharmaceutical Advisory Board

By Jennifer Harrell, Research Analyst Generations of hopeful party planners and anxious hostesses have turned to Emily Post as the authority on all things etiquette. Her gentle but firm guidelines on manners and social norms may seem more appropriate...
 

8.8.2013 Sales

The Key to Key Account Management: Unlocking the Potential of Pharma Sales Forces

By Christie Shilling, Research Analyst It’s old news: Gone are the days of the massive pharmaceutical rep armies.  Pharma companies have been trimming down their sales forces and looking for new ways to make the most of their physician relationships. ...
 

6.27.2013 KOL Management

Thought Leader Segmentation Helps Alleviate Regulatory Pressures

By Yanis Saradjian, Director of Consulting Last month, the French version of the U.S. Sunshine Act was implemented, forcing medical device makers to report all exchanges of value to healthcare professionals in excess of €10, in a first step that...
 

6.21.2013 KOL Management

Drug Companies Pay More for Research Than for Promotional Speeches

By Elio Evangelista, Director of Operations Although the government has varying motivations for requiring drug and device companies to disclose the payments they make to physicians, one consequence — intended or otherwise — is that companies...